Fasciola hepatica-induced acute pancreatitis: Report of two cases and review of the literature

Turkish Journal of Gastroenterology

Volumn 21, Issue 2, 2010, Pages 183-187

  Sezgin, Orhan ^a   Altintaş, Engin ^a   Tombak, Anil ^a   Üçbilek, Enver ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Acute pancreatitis; Fasciola hepatica

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL LIPASE; TRICLABENDAZOLE;

ABDOMINAL TENDERNESS; ACUTE PANCREATITIS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE PANCREATITIS; BILE DUCT DILATATION; BILIRUBIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CASE REPORT; CHOLANGIOGRAPHY; COMMON BILE DUCT; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; EOSINOPHIL COUNT; EOSINOPHILIA; FASCIOLA HEPATICA; FEMALE; FEVER; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTESTINE SOUND; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MALE; NAUSEA; PARASITE; PHYSICAL EXAMINATION; SINGLE DRUG DOSE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UPPER ABDOMINAL PAIN;

ACUTE DISEASE; AGED; FASCIOLIASIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS;

EID: 77956926269     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0081     Document Type: Article

References (25)

1. Bourke JB. Incidence and mortality of acute pancreatitis. Br Med J 1977; 2: 1668-9.
2. Seligson U, Cho J-W, Ihre T, Lundh G. Clinical course and autopsy findings in acute and chronic pancreatitis. Acta Chir Scand 1982; 148: 269-74.
3. Maroy B, Moullot P, Daloubeix H, Mathey JC. Acute pancreatitis complicating biliary distomatosis caused by Fasciola hepatica in a patient with a choledochal diverticulum. Ann Gastroenterol Hepatol (Paris) 1987; 23: 67-70.
4. Hauser SC, Bynum TE. Abnormalities on ERCP in a case of human fascioliasis. Gastrointest Endosc 1984; 30: 80-2.
5. Veerappan A, Siegel JH, Podany J, et al. Fasciola hepatica pancreatitis: endoscopic extraction of live parasites. Gastrointest Endosc 1991; 37: 473-5.
6. Echenique-Elizondo M, Amondarain J, Liron de Robles C. Fascioliasis: an exceptional cause of acute pancreatitis. J Pancreas 2005; 6: 36-9. (Pubitemid 41573833)
7. Parsak CK, Kolta. IS, Sakman G, et al. Surgery in Fasciola hepatica pancreatitis: report of a case and review of literature. Z Gastroenterol 2007; 45: 313-6.
8. Price T, Tuazon C, Simon G. Fascioliasis: case reports and review. Clin Infect Dis 1993; 17: 426-30.
9. Mahmoud AAF. Trematodes (schistosomiasis) and other flukes. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995; 2538-44.
10. Arjona R, Riancho J, Aguado J, et al. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine (Baltimore) 1995; 74: 13-23.
11. Harinasuta T, Bunnag D. Liver, lung and intestinal trematodiasis. In: Warren KS, Mahmoud AF, eds. Tropical and geographical diseases. 2nd ed. New York, NY: McGraw- Hill, 1990; 473-89.
12. Chen MG, Mott KE. Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 1990; 87: R1-38.
13. Özturhan H, Emekdaş G, Sezgin O, et al. Seroepidemiology of Fasciola hepatica in Mersin province and surrounding towns and the role of family history of the fascioliasis in the transmission of the parasite. Turk J Gastroenterol 2009; 20(3): 198-203.
14. Carpenter HA. Bacterial and parasitic cholangitis. Mayo Clin Proc 1998; 73: 473-8.
15. Sezgin O, Altintaş E, Dişibeyaz S, et al. Hepatobiliary fascioliasis: clinical and radiologic features and endoscopic management. J Clin Gastroenterol 2004; 38: 285-91. (Pubitemid 38233340)
16. Bell DR. A new method for counting Schistosoma mansoni eggs in the faeces with special reference to therapeutic trials. Bull World Health Organ 1968; 29: 525.
17. Harris NL, McNeely WF, Shepard JAO, et al. Case records of the Massachusetts General Hospital. Weekly Clinicopathological Exercises. N Engl J Med 2002; 346: 1232-9.
18. Espino AM, Dumenigo BE, Fernandez R, et al. Immunodiagnosis of human fascioliasis by enzyme-linked immunosorbent assay using excretory-secretory products. Am J Trop Med Hyg 1987; 37: 605-8. (Pubitemid 18030052)
19. VanBeers B, Pringot J, Geubel A, et al. Hepatobiliary fascioliasis: non-invasive imaging findings. Radiology 1990; 174: 809-10. (Pubitemid 20089676)
20. Isseroff H, Sawma JT, Reino D. Fascioliasis- role of proline in bile duct hyperplasia. Science 1977; 198: 1157-9. (Pubitemid 8241775)
21. Aubert A, Meduri B, Prat F, et al. Fascioliasis of the common bile duct: endoscopic ultrasonographic diagnosis and endoscopic sphincterotomy. Gastroenterol Clin Biol 2001; 25: 703-6.
22. Lluch JF, Presa F, Elcuaz R, et al. Visualization of motile leaf-like forms using endoscopic retrograde cholangiopancreatography. Enferm Infecc Microbiol Clin 1997; 15: 491-2. (Pubitemid 28012996)
23. Markwalder K, Koller M, Goebel N, Wolff K. Fasciola hepatica infection: successful therapy using triclabendazole. Schweiz Med Wochenschr 1988; 118: 1048-52.
24. El-Karaksy H, Hassanein B, Okasha S, et al. Human fascioliasis in Egyptian children: successful treatment with triclabendazole. J Trop Pediatr 1999; 45: 135-8. (Pubitemid 29267563)
25. Triclabendazole and fascioliasis: a new drug to combat an age-old disease. Fact Sheet No. 191. Geneva, Switzerland: World Health Organization, April 1998.